V. Leblond
- Oncology top 1%
- Pathology and Forensic Medicine top 0.5%
- Hematology top 0.5%
- Genetics top 1%
- Immunology top 5%
- Co-authors
- Laurent SuttonFrédéric DaviFrédéric CharlotteRichard DorentMarc‐Olivier BitkerBrigitte AutranNöel MilpiedSylvain Choquet
- Topics
- Lymphoma Diagnosis and Treatment (28 papers)Chronic Lymphocytic Leukemia Research (27 papers)Viral-associated cancers and disorders (16 papers)
- Partner nations
- FranceGermanyUnited States
In The Last Decade
V. Leblond
90 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 97
- Oncology 1.7k
- Pathology and Forensic Medicine 1.3k
- Hematology 1.3k
- Genetics 874
- Immunology 826
Countries citing papers authored by V. Leblond
This map shows the geographic impact of V. Leblond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Leblond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Leblond more than expected).
Fields of papers citing papers by V. Leblond
This network shows the impact of papers produced by V. Leblond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Leblond. The network helps show where V. Leblond may publish in the future.
Co-authorship network of co-authors of V. Leblond
This figure shows the co-authorship network connecting the top 25 collaborators of V. Leblond. A scholar is included among the top collaborators of V. Leblond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Leblond. V. Leblond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 30 | |
| 3 | 90 | |
| 4 | 72 | |
| 5 | 3 | |
| 6 | 36 | |
| 7 | 4 | |
| 8 | Efficacy and safety of sequential treatment with rituximab and CHOP chemotherapy in B-cell PTLD: Results of a prospective international phase II study | 1 |
| 9 | 106 | |
| 10 | 19 | |
| 11 | 67 | |
| 12 | 7 | |
| 13 | 57 | |
| 14 | 24 | |
| 15 | 19 | |
| 16 | 22 | |
| 17 | 13 | |
| 18 | 85 | |
| 19 | 211 | |
| 20 | 20 |
About V. Leblond
V. Leblond is a scholar working on Genetics, Hematology and Pathology and Forensic Medicine, having authored 92 papers that have together received 3.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (28 papers), Chronic Lymphocytic Leukemia Research (27 papers) and Viral-associated cancers and disorders (16 papers). The work is most often cited by research in Hematology (1.3k citations), Genetics (874 citations) and Pathology and Forensic Medicine (1.3k citations). V. Leblond has collaborated with scholars based in France, Germany and United States. Frequent co-authors include Laurent Sutton, Frédéric Davi, Frédéric Charlotte, Richard Dorent, Marc‐Olivier Bitker, Brigitte Autran, Nöel Milpied, Sylvain Choquet, Patrice Debré and Marine Diviné. Their work appears in journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.